Inogen Inc Stock Analysis

Inogen Stock Analysis Notes

About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Inogen Inc recorded a loss per share of 0.98. The entity had not issued any dividends in recent years. Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. Inogen operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1021 people. To learn more about Inogen Inc call Nabil Shabshab at 805 562 0500 or check out https://www.inogen.com.

Inogen Inc Investment Alerts

Inogen Largest EPS Surprises

View All Earnings Estimates

Inogen Environmental, Social, and Governance (ESG) Scores

Inogen Thematic Classifications

Inogen Stock Institutional Investors

Note, although Inogen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Inogen Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 158.55 M.

Inogen Profitablity

The company has Profit Margin (PM) of (0.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.

Management Efficiency

Inogen Inc has return on total asset (ROA) of (0.0621) % which means that it has lost $0.0621 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1327) %, meaning that it created substantial loss on money invested by shareholders. Inogen's management efficiency ratios could be used to measure how well Inogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 5th of February 2026, Return On Tangible Assets is likely to grow to -0.15. In addition to that, Return On Capital Employed is likely to grow to -0.21. At this time, Inogen's Non Currrent Assets Other are very stable compared to the past year. As of the 5th of February 2026, Deferred Long Term Asset Charges is likely to grow to about 23.2 M, while Total Assets are likely to drop about 294.4 M.

Technical Drivers

As of the 5th of February, Inogen retains the Risk Adjusted Performance of (0.12), market risk adjusted performance of (0.75), and Standard Deviation of 2.74. Inogen technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Inogen Inc Price Movement Analysis

Inogen Inc Insider Trading Activities

Inogen Outstanding Bonds

Inogen Predictive Daily Indicators

Inogen Corporate Filings

Inogen Forecast Models

Inogen's time-series forecasting models are one of many Inogen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Inogen Inc Debt to Cash Allocation

Inogen Inc currently holds 19.41 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. Inogen Inc has a current ratio of 5.21, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Inogen's use of debt, we should always consider it together with its cash and equity.

Inogen Total Assets Over Time

Inogen Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Inogen uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Inogen Debt Ratio

10.0

It appears that most of the Inogen's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Inogen's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Inogen, which in turn will lower the firm's financial flexibility.

Inogen Corporate Bonds Issued

Inogen Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Inogen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Inogen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Inogen. By using and applying Inogen Stock analysis, traders can create a robust methodology for identifying Inogen entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inogen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Inogen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Inogen Inc stock analysis indicators help investors evaluate how Inogen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Inogen shares will generate the highest return on investment. By understating and applying Inogen stock analysis, traders can identify Inogen position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Investors evaluate Inogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Inogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Inogen's market price to deviate significantly from intrinsic value.

Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Inogen's market price signifies the transaction level at which participants voluntarily complete trades.